More Impedimed Limited news
Impedimed LimitedASX: IPD

SOZO Pro Achieves Clearance by U.S. FDA

May 4, 2023 at 10:39 PM EDT · Issued by Impedimed Limited

Filed with ASX · May 4, 2023 at 10:39 PM EDT

On 6ix: 6ix.com/news/sozo-pro-achieves-clearance-by-us-fda

Watch Impedimed's latest call↗Impedimed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of Impedimed (ASX:IPD) Q1 2027 Earnings Call↗

Impedimed Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Impedimed Limited on 6ix

Story so far

  • FDA Clearance for SOZO Heart Failure IndexApr 22, 2021

Earlier from Impedimed

  • Appendix 4C & Quarterly Activities Report - Mar-23 QtrApr 16, 2023
  • NCCN Guidelines Now Recommend Bioimpedance SpectroscopyMar 26, 2023
  • S&P DJI Announces March 2023 Quarterly RebalanceMar 3, 2023
  • Appendix 4C & Quarterly Activities Report - Dec-22 QtrJan 29, 2023
  • New Version of NCCN Guidelines for Breast CancerJan 29, 2023

Later from Impedimed

  • Trading HaltMay 17, 2023
  • Placement and SPP NotificationMay 18, 2023
  • Capital Raising Investor PresentationMay 18, 2023
  • First Published Medical Policy for Bioimedance SpectroscopyMay 24, 2023
  • Share Purchase Plan OpensMay 30, 2023
All Impedimed news releases↗

Follow Impedimed into a list and get an email when it puts out news.

Follow Impedimed
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer